Forster J, Streckert H J, Werchau H
Children's Hospital, Albert-Ludwigs-University, Freiburg.
Klin Padiatr. 1995 Nov-Dec;207(6):313-6. doi: 10.1055/s-2008-1046559.
In this study the immune response of 29 newborns and infants hospitalized on behalf of a RSV infection was evaluated. Acute phase and convalescent sera were examined by a neutralization assay, in an immunoblot, and in an ELISA based on 10 synthetic peptides derived from RSV proteins. The last two tests allow to monitor the synthesis of RSV specific antibodies of the infant. Despite the presence of maternal antibodies the initial immune response seems to be random and favours linear epitopes of the protein backbone of viral proteins. The earliest protecting antibodies directed against glycosylated epitopes are acquired in the second half year of life. Antibodies generated during the primary immune response seem to predispose infected children to get ill.
在本研究中,对29名因呼吸道合胞病毒(RSV)感染而住院的新生儿和婴儿的免疫反应进行了评估。急性期和恢复期血清通过中和试验、免疫印迹法以及基于10种源自RSV蛋白的合成肽的酶联免疫吸附测定(ELISA)进行检测。后两种检测方法可用于监测婴儿RSV特异性抗体的合成。尽管存在母体抗体,但初始免疫反应似乎是随机的,且倾向于病毒蛋白主干的线性表位。针对糖基化表位的最早保护性抗体是在生命的后半期获得的。初次免疫反应期间产生的抗体似乎使受感染儿童更易患病。